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HHP

Method development for the quantitation of glucose and [6,6-^H] glucose in human
plasma samples using LC/MS.

Director: Dr. Brent Rul

The purpose of this research was to develop a method that accurately detects the
enrichment of [6,6-^H] glucose in human plasma samples via LC/MS. Traditionally, the
analysis of [6,6-^H] glucose has been conducted using GC/MS. The benefit to a LC/MS
method is the avoidance of derivatizing glucose for analysis as is required with GC/MS.
Method: Plasma samples were acquired from five female subjects participating in an
exercise study. Each subject performed a 60-minute cycle ergometry exercise bout while
being infused with [6,6-^H] glucose. Additional plasma was obtained from a previously
conducted exercise study, which acquired data by GC/MS. Three different ionization
techniques were explored; negative ion electro spray (ESI) LC/MS, negative ion
atmospheric pressure chemical ionization (APCI) LC/MS, and positive ion ESI LC/MS.
Results: The data with the best signal, peak resolution, and signal to noise ratio were
acquired using positive ion ESI LC/MS. Data did not match previously measured
enrichments by GC/MS and predicted trends were not exhibited by the freshly acquired
plasma samples. Accurate results were obtained when analyzing glucose standards
mixed in DDI water and spiked with 1-5% [6,6-^H] glucose (R^ = 0989). On the
contrary, data resulting from glucose standards again spiked 1-5% with [6,6-^H] glucose
but that were from plasma showed no discernible trends (R^ = 0.187). Discussion: The
problem with the analysis of [6,6-^H] glucose was unique to samples coming from
plasma. The isotopic peaks were larger than predicted for background samples and for
samples drawn after the infusion started. A contaminant molecule with the same
molecular weight as the isotope was suspected. Sorbitol, a reduced form of glucose has
the nrolecular weight of 182 amu and was pursued as a candidate. Glucose standards in
DDI water spiked with sorbitol showed a ten-fold increase in the measurement of
theoretical enrichments (R^ = 0.998). Conclusion: Further research is needed in the
development of a LC/MS method. Techniques for better separation of glucose from
contaminant molecules should be employed. The use of carbohydrate LC columns
specifically made to separate monosacharrides may improve separation, as may the use of
a quadrupole mass analyzer.
ii
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Chapter One: Introduction

In 1959 Steele established a m ethod for measuring the turnover rate and size o f
the body’s glucose pool using a stable isotope (Steele, 1959). This method has been
widely used in the field o f exercise science to measure the appearance rate o f metabolic
substrates found in the blood. Steele’s method has since been modified by Wolfe and is
utilized today by researchers when measuring glucose kinetics in vivo (Wolfe, 1992).
Metabolic research using [6,6-^H] glucose has become increasingly important to the field
o f exercise science and especially carbohydrate feeding studies. Quantitation o f glucose
metabolism involves the use o f stable and/or radioactive isotopes.

In order to limit the

risk incurred by human subjects, stable isotopes are employed to avoid any ill effects o f
radiation. The use o f [6,6-^H] glucose enables researchers to assign relative proportions
o f carbohydrate oxidation rates to either glycogen stores or blood glucose.
An understanding o f glucose metabolism is needed in order to provide accurate
recommendations on nutrition, training, and performance for competitive athletes.
Glucose kinetics is o f particular importance to the endurance athlete who may deplete
carbohydrate stores over the course o f an event and m ust rely heavily on exogenous
sources o f glucose.

Performance and rate o f recovery may be enhanced w ith proper

carbohydrate intake before, during, and after competition (Febbraio et al., 2000).

A

better understanding o f glucose metabolism will not only benefit athletes but also those
with various medical conditions or jo b related environmental stresses. People working in
very hot o r cold ambient temperatures, patients suffering fi-om thermal injuries, and
1
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pregnant women face conditions that alter energy expenditure and thus energy intake.
The elucidation o f nutritional requirements for these populations as well as athletes may
be aided by metabolism studies that utilize [6,6-^H] glucose.
Analysis o f [6,6-^H] glucose can lead to the determination o f relative blood
glucose and stored glycogen oxidation rates. This requires the use o f a mass
spectrometer (MS), which evolved from w ork done in 1912 by J.J. Thonqjson (Siuzdak,
1996). MS provides information on a m olecule’s molecular weight and/or structure. In
exercise physiology, mass spectroscopy has been used for the analysis o f isotope data
gathered from metabolic studies. The MS detects the enrichment o f an isotopic tracer
molecule within the tracee pool. It is this enrichment that enables the quantitation o f a
particular metabolite’s disposal and uptake rates. Traditionally, metabolic studies using
[6,6-^H] glucose have used gas-chromatography mass spectrometry (GC/MS) (Febbraio
et al, 2000, Marmy-Conus et al., 1996, Freidlander et al., 1998, Zderic et al., 2001). The
GC/MS is a gas chromatographic system that uses a mass spectrometer as a detector. The
GC separates compounds that are thermally stable, chemically inert, and volatile at
temperatures generally below 300® C (James et al., 1952). The sample is vaporized and
carried through a column by an inert gas, usually helium. Most substances within the
body are not thermally stable, chemically inert or volatile.
The five OH functional groups in hexoses like glucose produce strong
intermolecular forces that decrease the molecules ability to vaporize as required for the
GC. Therefore, glucose must be made into a derivative for GC/MS analysis.
Derivatization masks the OH groups and increases the molecules volatility, which
2
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facilitates GC/MS analysis. The pentaacetyl derivative o f glucose is used for GC/MS
analysis. Assumptions must be made that all five o f the OH functional groups acquire an
acetyl group with 100% conversion (Wolfe, 1992). I f one o f the five functional groups is
not converted, the MS will not detect the molecule as glucose, possibly lowering
sensitivity. This presents an appealing challenge to find a w ay to analyze glucose in its
native, underivatized form.
James McLafferty developed liquid-chromatography mass spectrometry in 1973
(Siuzdak, 1996), seventeen years after the advent o f GC/MS. This kind o f interfacmg
with the mass spectrometer does not require the derivatization o f glucose and is,
therefore, more suitable for analyzing biological substrates. Currently, there are several
common LC interfacing techniques available. These techniques differ in their optimal
analyte, ionization type, and maximum solvent flow rates (Chapman, 1998).

The

evolution o f electrospray ionization (ESI) has facilitated the use o f LC/MS methods for
polar molecule analysis, negating the need for derivatization (Chapman, 1998 and Gelpi
1995).

ESI is accomplished by charging the sample liquid in a narrow-bore metal

capillary.

Small charged droplets are formed.

Eventually desorption o f the sample

occurs firom the droplets and it is sent into the mass spectrometer.

ESI is the best

interfacmg candidate for establishing a method to analyze glucose fi’om plasma samples
because o f its mild ionization and low thermal input.
Reid et al., 1990 proposed a methodology in 1990 using thermospray LC/MS to
analyze enrichments o f [1-^Hi] glucose in human plasma samples. To date, this is the
only LC/M S method used for the analysis o f plasma glucose enrichments. The method
3
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uses negative ion thermospray LC/MS to measure the enrichment o f [1-^Hi] glucose in
plasm a samples. Since this work, electrospray (ESI) LC/MS has replaced therm ospray
and revolutionized biomolecular analysis. The purpose o f our research is to develop a
LC/M S m ethod for the determination o f carbohydrate utili2atio n patterns.
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Problem
To develop a method for the evaluation o f [6,6-^H] glucose enrichments using LC/M S.
This study seeks to determine optimal sample prep, LC, and mass spectrometer
conditions for proper analysis. The data provided will help determine if LC/M S is an
appropriate method for this type o f analysis.

Research Hypothesis
Hypothesis One
Plasma glucose enrichments u sir^ [6,6-^H] glucose can be deterrnined using LC/M S.
Justification
LC/MS is an appealing technique for glucose enrichment analysis since glucose
derivatization is not necessary.
Hypothesis Two
The results obtained by LC/MS should mirror results obtained via GC/MS.
Justification
Both GC/MS and LC/MS require the same purification steps with the exception o f
derivatization. Assuming this step does not profoundly change the amount o f glucose in
each sample, LC/MS should detect similar enrichments.

Significance o f the Study
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There is widespread use o f the [6,6-^H] glucose isotope in metabolic research. To our
knowledge GC/MS is the only method utilized in these studies. This method requires the
addition o f an acetyl functional group to all five o f the OH functional groups o f glucose.
Only one published study has used LC/M S to find enrichments for plasma glucose and no
studies have been published using ESI LC/M S for the [6,6-^H] glucose isotope.

Rationale for the Study
The development o f an LC/MS protocol for the analysis o f plasm a glucose will
complement existing methods o f analysis, offering the possibility o f examining multiple
analytes, and permit high-throughput to researchers with the option o f using LC/MS.
Analyzing glucose in its native form eliminates concern over derivatization and artifact
production.

Limitations
1/ Sensitivity. TOP MS is not as sensitive as a quadrupole MS for single ion
monitoring (SIM) conditions.
2/ Sample prep. Plasma samples w ere thawed and refrozen several times
throughout the course o f analysis. To avoid degradation o f samples, they were only
thawed for the time needed to collect sample and immediately refrozen. Additionally,
once purified samples were transferred into auto sampler vials they were kept frozen in 80®C freezer.
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3/ Plasma samples. A limited volume o f plasm a was available to perform
experiments. Old samples from a previous study collected four years prior to this
research were used during method development.

Definition o f Terms
LC/MS. Liquid-chromatography mass spectrom etry refers to a liquid chromatography
system w ith a mass spectrometer as a detector.
GC/MS. Gas-chromatography mass spectrometry refers to a gas chromatography system
with a mass spectrometer as a detector.
Tracer. Labeled metabolite infused to study a metaboHte o f interest.
Tracee. The metabolite whose kinetics are being examined.
Ra. The rate o f appearance o f a given m etabolite into the circulation.
Rd. The rate o f disposal o f a given metabolite out o f the circulation.
Isotopic enrichment. The ratio o f tracer to tracee determined with liquid
chromatography-mass spectrometry. Used to calculate Ra and Rd.
[6»6-^H] Glucose. A glucose molecule in w hich the two hydrogens on carbon six have
been replaced with deuterium. This molecule is stable and used to measure glucose
kinetics in vivo.
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C hapter Two: M ethodology

M aterials and M ethods
Human Subjects
Plasma samples were obtained from five recreationally active female students from The
University o f M ontana campus. Subjects were 18-23 years old and volunteered for this
study. Subjects completed consent forms (Appendix) and were made aware o f the rigor
o f the study as well as risks involved with the procedures. Subjects reported to the lab for
two tracer trials once during the mid follicular and once during the mid luteal phase o f
their m enstrual cycle. The University o f Montana Institutional Review Board (IRB) and
Human Subjects Committee approved the study (Appendix).

Body composition
Hydrostatic weighing with a digital scale (Exertech, D resbacfr MN) at residual lung
volume was used to calculate percent body fat and fat free mass. The residual lung
volume was calculated using a H elium dilution technique using calculations developed
by G oldm an and Becklace. Calculations for percent body fat utilized body density and
age/gender specific equations (Lohman, 1992).

Exercise tests
Subjects were instructed to refrain from the ingestion o f nicotine, caffeine, alcohol, and
food 10 hours prior to exercise trials and to refrain from exercise 15 hours before exercise
8
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testing. Subjects reported to the lab for peak VO 2 (volume o f oxygen consumed)/ lactate
threshold determination one week to one month before experimental trials began. All
exercise tests were conducted on a M onark cycle ergometer (Model 824E). A modified
TrueM ax 2400 Parvo-medics (Salt Lake City, UT) metabolic system was used to analyze
expired oxygen and carbon dioxide concentrations. The system was equipped with a
Hans Rudolph (Hans Rudolph, Inc., Kansas City, MO) medium-flow (10-120 L m in’^)
pneum otach along with Beckman oxygen and carbon dioxide analyzers. Prior to each
test the metabolic system was calibrated with known concentrations o f O 2 and CO 2
(15.2% and 5.17%). The system was recalibrated if gases were not within 5.0% o f known
values. Flow rate was calibrated using a 3L syringe per manufacturer’s instructions
(Parvo-medics Operators Manual, 1999). During testing, heart rate was continuously
monitored using a telemetry chest strap and monitor (Polar, Port Washington, NY).

Peak VO 2 / Lactate Threshold cycle test
The first lab visit was a peak VO 2 / lactate threshold test. Prior to the test a venous
catheter was placed in an antecubital vein for blood sampling throughout exercise. In
order to prescribe exercise intensities, blood samples were collected for lactate threshold
determination. VCO 2 , VO 2 and respiratory exchange ratio (RER) were collected every 20
seconds. The protocol consisted o f a 5-minute warm-up followed by 2-minute stages
starting at 58.8 W and increased approximately 10 W each stage until volitional
exhaustion. Peak VO 2 was defined as reaching two o f the following three criteria: an
R ER value above 1.0, a plateau in VO 2 and a H R greater that 95% o f predicted maximal
9
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HR. Blood samples o f 1-2 ml were drawn the last 20 seconds o f each 2 minute stage.
The test was stopped when the subject met tw o o f the three peak VO 2 criteria.
Immediately after each sample was collected, 0.5 ml o f w hole blood was added to a test
tube containing 1 ml o f chilled 7% perchloric acid and frozen at -20 ®C until samples
were thawed and centrifuged. The supernatant was removed and lactate concentrations
were later determined using a spectrophotometric method. The estimated lactate
threshold power output was determined as the last workload before a nonlinear increase
in blood lactate concentration. The highest recorded heart rate was reported as the
subject’s maximal heart rate.

Experimental Trial
Subjects reported to the lab at 6:00 a.m., approximately 10 hours fasted. Indwelling
catheters (18-20 gauge Teflon) were placed in an antecubital vein o f each arm and kept
patent with a continuous saline drip (0.45% sodium chloride). A background sample o f 4
ml w as drawn before a primed constant infusion o f the isotope [6,6-^H] glucose
(Cambridge Isotope Laboratories, Andover, M A) was started. The 10-minute priming
dose w as 4.0 pmol/kg min"', which was followed by a 50-minute constant infusion at a
rate o f 0.40 pmol/kg min'* in order to reach isotopic equilibrium. A Harvard infusion
pump (Cambridge Isotopes Laboratories, Woburn, MA) depressed a 60-ml syringe
containing the isotope. Next, an oral glucose bolus o f 2.0 g o f glucose / kg fat free mass
(FFM) (Fisher) was given in a 22% solution. The subject remained sedentary for 20
minutes before beginning the exercise session at 90% o f lactate threshold on a cycle
10
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ergometer. Blood samples were taken every 5-10 m inutes throughout exercise (see
timeline).

Analysis

Blood sampling timeline:
Priming d w e
4.0 pimol/kg min '

Constant infusion 0.40 (xmoi/kg min'^
CHO Drink

-60

-2

0 10 20 25 30 40 50 60

F igure 2.1. Total blood volume drawn = 65 ml, each sample will contain from 4-10 ml +
1.5 ml discard.

Blood samples were collected in EDTA treated tubes for the analysis o f glucose and in
plain glass tubes containing chilled 7% perchloric acid for plasma lactate. Glucose and
lactate concentrations were analyzed using an enzymatic (Sigma) spectrophotometric
technique (Milton Roy Spectronic 401). Samples drawn for each tim epoint were
analyzed for plasma glucose and samples drawn at time 0, 30, and 60 o f exercise were
analyzed for plasma lactate. Samples from each subject were analyzed together in
duplicate.

11

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Hardware a n d Reagents
Polypropylene test tubes w ith cap, 12 x 75 mm w ere obtained jfrom Fisher Scientific
(Pittsburgh, Pennsylvania, USA). Zinc sulphate (0.3 N, 14-4) barium hydroxide (0.3 N,
14-3) and mixed-bed ion exchange resin (TM D-8) were obtained from Sigma Chemical
Co. (St. Louis, Missouri, USA). [6,6-^H] Glucose was obtained from Cambridge Isotope
Laboratories (Andover, Massachusetts, USA). D-Glucose (anhydrous) was obtained
from M allinckrodt Baker, Inc. (Paris, KT, USA).
Apparatus
High performance liquid chromatography/mass spectroscopy (HPLC/M S) was
carried out using a M icroM ass LCT mass spectrometer running in the positive ion mode.
The HPLC was performed with a Waters 2790 pump on a Symmetry C,g (3.5 pm , 2.1 x
50 mm i.d.) (W aters Corporation, Milford, M assachusetts, USA), 20 pi injection w ith a
flow rate o f im l/m in (2/98 acetonitrile: water). Glucose and [6,6-^H] glucose were
observed as their sodiated species yielding mass spectral peaks corresponding to
[M+Na]^ o f 203 (180 + 23) and 205 (182 + 23), respectively.
The mass spectrometer was equipped w ith the electrospray source with the
settings: capillary voltage = 3200 V; sample cone = 10 V; extraction cone = 5 V; ESI
desolvation temperature = 400 ®C; source temperature = 1 5 0 ®C; desolvation gas flow ~
650 1/hr.

12
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Subject's Blood
collected in
nonheparinized
syringe
1 ml into PGA tubes
for lactate and
glycerol at Time
points 0,30,60
3 ml into plain glass
tubes for Insulin at
Time points -2, 0, 30
.60

4 mt into
EDTA tube
for olucose
1/2 of supernatant
into plastic tube for
[glucose] frozen 20

3/4 of supernatant
into plastic tubes
for isotopic
enrichment of
glucose frozen at
-20

4 ml into plain
glass tubes for
Estrogen and
Progestertme
at Time point -

Tubes into -80
degree C freezer for
10-15 minutes and
then into lyophilizer

Samples
reconstituted in
500 )xl DDI
water

Figure 2.2.
analysis.

Remaining
plasma
archived

Add supernatant
to mixed-bed ion
exchange column
Rinse with 400 pi
DDI water x 5

500 nl plasma +
750 ul Ba(0H)2
750 pi ZnS04
Vortex

On ice for 20
minutes then
centrifuge for
20 minutes

Transfer into HPLC
auto sampler vials
for mass
spectrometric
analysis

Glucose isolation and purification from obtaining subjects blood to LC/MS

13

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Sam ple preparation
Plasma serum samples (500 pL ) were added to 12 x 75 mm test tubes and
deproteinized by the addition o f barium hydroxide (0.3 N, 750 pL) and zinc sulphate
(0.3M , 750 pL), vortexed and stored on ice for 20 minutes. The tubes were then
transferred to the speed vac centrifuge and spun at maximum speed for 20 minutes in a
cold room at 4 ®C. The tubes were removed and the supernatant was added to a mixedbed ion exchange column (3 mL disposable syringe, filled to 1.5 mL, Becton Dickinson
and Company, Franklin Lakes, NJ) and the column was washed five times (400 pL) with
double de-ionized (DDI) water (2500 pL , total volume). The resultant solution was
lyophilized and the residue was reconstituted in DDI water (500 pL), transferred to an
HPLC auto sampler vial and kept frozen at —80 ®C until HPLC/MS analysis. The thawed,
vortexed samples w ere injected into the HPLC/MS (20 pL) and the mass spectral peaks
corresponding to 203 and 205 were monitored. The ratio o f 205 to 203 was calculated
for each time point.

Standards
Two sets o f standard solutions were prepared, one in water and the other in
plasma. Stock solutions o f [6,6-^H] glucose (Cambridge Isotope Laboratories, Andover
M A) and D-glucose (Mallinckrodt Baker, Inc., Paris, KT) at 5 mM concentrations were
prepared in DDI water. Serial dilutions were made at 1%, 2%, 3%, 4%, and 5% [6,6-^H]
14
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glucose enrichments. A second set o f standard stock solutions were mixed. A 10 mM
[6,6-^H] glucose solution was added to aliquots o f a 6.97 mM plasm a sample. Again
dilutions were made and plasma samples were spiked from 1-5% with [6,6-^H] glucose.

A nalysis o f Standards
The above standard solutions were prepared to determine the accuracy o f the
LC/MS values. Analysis o f standards was conducted in a manner that would also assess
the effect o f the sample prep protocol as expressed in the procedure below.
Procedure:
The blank (100) pi, 1%, 2%, 3%, 4%, and 5% standards in water were transferred to
HPLC auto sampler vial and analyzed before any sample prep occurred. Deproteinizing
agents were added to the remaining solution as stated in sample prep section but with
volumes adjusted, put one ice for 20 minutes, centrifuge in the cold room for 15 minutes,
and the supernatant was transferred into HPLC auto sampler vials for analysis. W ith 250
pi o f the above standards the full sample prep (deproteinization, chromatography and
lyophilization) was conducted before analysis. Because proteins in the plasma may clog
the HPLC sampler, spiked plasma standards were only analyzed after the deproteinizing
step and after co n p lete prep.

Statistical Procedures
1) Glucose (pre exercise 0, 10, 20, 30, 40, 50, and 60 minutes o f exercise) and lactate
(time 0, 30, and 60 o f exercise) concentrations were determined using a SuperAnova
15
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statistical package (Abacus, Inc, Berkeley, CA). The level o f significance was set at an
overall experimental alpha o f 0.05.
2) Descriptive variables VO 2 peak (ml kg'* min'*) and % VO 2 peak at lactate threshold
w ere reported expressed as mean plus or minus standard error.

16
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C h a p te r T h ree: R esults a n d D iscussion
Subject characteristics
Plasma samples were taken from five recreationally active females tested during the
follicular and luteal phases. The physical characteristics are reported in Table 1.

None

o f the subjects were using oral contraceptives and all were menstruating normally for the
six months prior to the study.

T able 3.1. Physical characteristics o f female subjects. Expressed as mean ± standard
deviation (n = 5).

+

1.7

Height (cm)

166.8 ±

6.9

Body Mass (kg)

64.69 +

12.7

Body Fat (%)

19.94 ±

4.3

Maximum Heart Rate (bpm)

193 ±

7

VO 2 peak (1/min)

3.07 ±

0.5

VO 2 peak (ml kg Vmin)

47.84 +

4.4

% V 0 2 peak @ lactate threshold

63.10 +

5.0

Age (years)

20
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W orkload Intensities during exercise trials
The intended exercise intensity w as 90% VO 2 at the lactate threshold (% VO 2 @ LT).
No differences were found w ith respect to workload intensity during the 60-minute
exercise trials.

Table 3.2. Workload intensities for the exercise trial reported expressed as mean +
standard deviation (n = 5). Early refers to 1-30 minutes o f exercise and late represents
31-60 minutes o f exercise during each trial.

Follicular
%V02
peak (ml/kg /min)
Early
Late

Luteal
%V02 peak
(ml/kg/min)
Early
Late

59.11+ 4 .4 5 58.86 + 4.84 57.72 + 4.84 59.76 + 5.66

Plasma glucose and lactate concentrations
There w ere significant dififerences in plasma glucose concentrations at time 0 and 10 o f
exercise after the oral bolus (2.0 g / kg FFM) was given. By minute 20 o f exercise,
plasm a glucose concentrations w ere normalized. Subjects demonstrated an excellent
ability o f normalizing blood glucose concentrations after such a large load. Plasma
lactate w as determined for time 0, 30, and 60 minutes o f exercise. There were no
significant differences between the menstrual phases but a main effect for time is

18
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indicated in Figure 3.2. Significant differences exist between time 0 and both exercising
tim e points (30 and 60).

7.5

f

6.5 -

-I 6 :

1 :
5.5

O

follicular

■

luteal

4.5

pre drink

0

10

20

30

40

50

60

Pre exercise and exercise time (min)

F ig u re 3.1. Plasma glucose response due to oral glucose load given 20 minutes before
exercise (n = 5).
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3.5

2.5

O

follicular

■

luteal

1.5

T

0

30
Pre exercise exercise time (min)

60

Figure 3.2. Plasma lactate concentrations illustrating a main effect for time at tim e 30
and 60 o f exercise (n = 5).

Substrate Oxidation
As indicated by Figure 3.3, subjects oxidized more carbohydrate during the luteal phase
than follicular phase. Previous research in our lab (Zderic et al., 2001) found the opposite
trend, reporting increased fat oxidation in the luteal phase, associated with elevated levels
o f estradiol and progesterone. The only differences between the previous study and the
present were the carbohydrate drink before exercise and a longer duration o f exercise at
the chosen intensity.
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Substrate Oxidation 1-60 minutes
120

i
f

100

Î

■ FAT
OCHO

£

F ig u re 3.3. Contribution o f fat and carbohydrate to substrate oxidation (1 = follicular, 2
= luteal).
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Plasm a p rep fo r LC /M S analysis
Ba(OH ) 2 and ZnS 0 4 were added to plasma samples to precipitate out proteins. The
samples were centrifuged and the supernatant was added to mixed-bed ion exchange
columns so that molecules other than glucose would be removed increasing the purity o f
each sample. Each column w as washed w ith DDI w ater and then lyophilized. Samples
were reconstituted in DDI w ater with the same volume o f the original plasma sample.

Ionization techniques explored
Negative ion electrospray LC /M S
The first technique utilized to detect glucose and [6,6-^H] glucose was negative ion ESILC/MS. Glucose, with a mass to charge ratio (m/z) o f 179 was observed with decent
signal intensity (Fig 3.4). However, the isotopic peak at m/z 181 sits in the background
noise (Fig 3.5). Areas under this peak were not quantitated because o f the large signal to
noise ratio. When comparing spectra from the front and back end o f the total ion
chromatogram, the 181 peak w as shifted slightly as indicated in Figure 3.6. The tracer
tracee ratio from the front end o f the peak was generally smaller than that calculated from
the back end. This was consistently observed w ith plasma samples analyzed in the
negative ion ESI mode. These observations led to the exploration o f other ionization
techniques and the question o f whether or not other molecules were co-eluting at the
isotopic peak.
22
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T e d 's S am p les am A7& N H40Ac
Glucose Study 2 9
0.54
lO O n

0 50

TOP MS EST IC

6.22e3

1.50

1.00

31-MAY-2CW110:16:26

KB170

2.50

2.00

3.00

Time

Figure 3.4. Total ion chromatogram (TIC) in negative ion ESI.
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Glucose Study 2 9 21 (0.356) Cm (14:22)
^QO 119 0211

^
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I I
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TOP MS ES899

179,0459
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300
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|t|

400

500

600
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Figure 3.5. Background noise in negative ion ESI.
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m/z
1000

r e d 's S am ples am 47 j5 NH40AC

KB170

31-MAY-2001
10:16:26

Glucose studv 2 9 27 f0.456^ Cm f27;401
179.0459
lOOn

TOP MS ES341

■ %-

180.9902

177.9652

TOP MS ES877

glucose study 2 9 21 (0.356) Cm (15:22)

100-,

179 0459
177.9652
178

180.0393
179

180

181

182

n\fz

Figure 3.6. Mass shift illustrated in negative ion ESI. The top (0.439) peak represents a
scan fi-om the back end o f the TIC and the bottom represents a scan fi-om the fi-ont o f
peak (0.356).

N egative ion A P C I
The next method explored was negative ion atmospheric pressure chemical ionization
(APCI). With this method, initial data showed improved signal intensity, lower
background and improved peak resolution (Fig 3.7 and 3.8). All samples fi*om the
exercise study were analyzed using this method looking at peaks 181/179 and the
chlorine-associated glucose at 217/215. Chlorinate-associated peaks were analyzed
because they consistently appeared in the spectra and both peaks were well above the
background noise. The 217 and 215 peaks were promising prospects to quantitate
enrichm ents because their signal intensities were not as dramatically different as the 179
24
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and 181 peaks. Slight differences in the tracer peak intensity did not change the tracer
tracee ratio (TTR) as drastically. But with either set o f peaks tracer tracee ratios w ere
higher than predicted especially for background samples (Table 3.3). Additionally, when
enrichments were plotted the data did not illustrate any discernible trends (Fig 3.9). The
high background values produced negative enrichments for time points occurring after
the tracer infusion started. When correcting for background values (taking theoretical
background values) there was still no observable trend. Enrichments are predicted to stay
constant over the course o f exercise but with a possible drop towards the end.
trends were not observed.
LDL 2

KB170

20^IUN^2001
20:28:46

Glucose Study 328 40 (0.668) Cm (34:43)
100-1 179.0909

180.0845
175

180

185

TOP MS AP-

215.0573
217.0636
.222.1075
206.1080 212.0776

196.0962
190

195

200

205

210

215

220

225

Figure 3.7. Improved background noise in negative ion APCI.
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mtz

These

20^UN-2001
20:28:46

KBI 70

L D t-2

TOP MS AP179.0909

100 -,

179

160.0645

181.1036

180

181

182

m/i

Figure 3.8. Peak resolution in negative ion APCI.

Table 3.3. Representative subject’s tracer tracee ratio (TTR) and enrichment (E) for
glucose (181/179) and glucose + chlorine (217/215). E = sample TTR - background
TTR.

Timepoint
-60

-2
0

10
20
25
30
40
50
55
60

E
E
181/179 181/179 217/216 217/215
7 .4 1 2 6 5 3
0
3 9 .7 8 5 9 5
0
7 .1 4 4 3 0 2 -0 .2 6 8 3 5 4 0 .3 9 1 9 4 0 .6 0 5 9 8 2
4 .8 1 7 4 9 5 -2 .5 9 5 1 6 3 7 .7 9 6 2 3 -1 .9 8 9 7 2
3 .8 2 6 5 0 6 -3 .5 8 6 1 5 3 6 .6 7 5 8 6 -3.1101
4 .1 0 9 3 9 8 -3 .3 0 3 2 5 3 4 .5 3 2 9 2 -5 .2 5 3 0 4
4.800821 -2 .6 1 1 8 3 3 6 .5 3 2 9 7 -3 .2 5 2 9 8
5 .1 1 5 8 2 4 -2 .2 9 6 8 3 3 8 .0 9 1 6 2 -1 .1 6 3 0 3
3 .4 4 6 5 9 -3 .9 6 6 0 6 3 5 .8 6 7 8 2 -3 .9 1 8 1 3
3 .5 5 2 0 5 9 -3 .8 6 0 5 9 3 5 .2 0 9 9 2 -4 .5 7 6 0 3
3 .8 0 0 3 2 5 -3 .6 1 2 3 3 3 5 .4 8 6 2 5 -4 .2 9 9 7
4 .9 94991 -2 .4 1 7 6 6 3 8 .5 1 6 1 2 -1 .2 6 9 8 3
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LB A v e ra g e e n ric h m e n ts (L u tea l)

|E 1S1A79

e 1X7ms

a

■

Figure 3.9. Time vs. enrichment for a representative subject in the exercise study.
Enrichments for 181/179 and 217/215 peaks are shown.

Chromatography
Chromatography was experimented with while searching for better separation o f glucose
from other molecules. The purpose o f running the samples through a LC column was to
increase purity and decrease the chance for a co-elutant at the tracer peak. Flow rates,
size o f the column, and solvent conditions were varied (water, acetonitrile, and
ammonium acetate). Unfortunately, running the samples through the column did not
27
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improve background, separation, or ionization. Without any improvement in the data
another ionization method was investigated and loop injections were made.

P ositive ion electrospray [M + N a] 205/203
Through communication with another laboratory it was recommended to look for the
sodiated peak [M + Na] o f glucose using positive ion ESI. The peaks appeared at m/z 203
and 205 w ith good signal intensity. This form o f ionization (cationization) is well suited
for carbohydrates because o f the electronegativity associated w ith their hydroxyl
functional groups. Standard solutions made up in double deionized water were prepared
to test the instrumentation before more plasma was used from the exercise study.
Glucose enriched 1-5% with [6,6

glucose was run through the mass spectrometer

(Fig 3.10). Actual enrichments were plotted against theoretical values. The mass
spectrometer accurately m easured the enrichments for the standards in water as indicated
by the standard curve (R^ = 0.9888) (Fig 3.15). The accuracy o f the instrument led to the
belief the m ethod would also measure plasma samples correctly. Therefore, two sets o f
plasma samples from the exercise study subjects were prepared and analyzed for
enrichment. Again the enrichm ents did not indicate the predicted trend and the samples
that were previously analyzed via GC/MS did not match LC/MS results (Table 3.4 and
Fig 3.16). Until this stage o f method development, it was thought problems with the data
were due to the ionization method. In order to elucidate why the plasma samples were
not accurately detected, a set o f spiked plasma standards were prepared as described in
28
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the m ethodology section (Fig 3.11, 3,12 and 3.13). When analyzing the spiked plasm a
standards a poor correlation was observed between theoretical values and experimental
values (R^ = 0.187) (Fig 3.16). It became clear that there was a problem seeing the
isotope peak in only the plasm a samples. An additional observation with the plasma
standards w as that a slight mass shift with the isotopic glucose peak was again detected
as w ith negative ion ESI. This indicates the possibility o f another molecule co-eluting
with [6,6 ^H] glucose. The intriguing point about the two sets o f standards was the
inaccuracy o f detecting enrichments for glucose that came from plasma. The enrichment
values for both blank and enriched plasma samples indicate a molecule with the same
molecular w eight that is artificially inflating these values.

SmM G lucose

KB170

9-AUG^001
09:29:55

Glucose StucJy Fresrv027e (0.021) Cu (0 05): Is (I.OO.1.00) C6H1206Na
.jQQ
203.0532

TOP MS ES+
9.21 e l 2

%
204.0532

T

Glucose study Freslv027e 54 (0.905) Cm (39:55)
.jPQ
203.1027
4
Ol

l\

203

\

^

TOP MS ES+
8.05e3

204.1122
"

'I

-T —

204

205

-

m/z

F ig u re 3.10. Positive ion ESI mode illustrating a 5mM standard solution in water (on the
bottom w ith the theoretical spectra on top).
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2% Plasma prep

30rAUG-200111:27:24

KB170

TOP MS ES+
TIC
6 80e3

Glucose Study Fresh-137
1.12

100 -,

0.50

1.00

1 50

2.00

2.50

3.00

F igure 3.11. Positive ion ESI mode showing a total ion chromatogram o f a 2% standard
solution prepared from human plasma.

No E Plasma prep

KB170

30-AU6-200111:19;52

Glucose Study Fresh-135 Sm (SG. 2x1 )
1.12:17.22
100 -,

TOF MS ES+
206 .124 0.20Da
56.1
Area

Glucose Study Fresh-135 Sm (SG. 2x1)
1.12:338.80
100-,

TOF MS ES+
203 103 0 200a
1.0263
Area

■ %-

0.50

1.00

1.50

2.00

2.50

3.00

Time

F igure 3.12. Positive ion ESI mode illustrating the integration o f background plasma
sample a 205 to 203 ratio o f 5.08%.
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6% Plasma prep

30-AU6-2001
11:38:51

KB170

TOP MS ES+
3 90e3

Glucose Study Fresh-140 56 (G 936) Cm (46:56)
203.1027
100-,

205 1243

204.1122
203

204

205

m/z

Figure 3.13. Positive ion ESI mode representing 5% standard solution prepared from
hum an plasma. Spectrum indicates an enrichment o f approximately 10%.
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Table 3.4. Comparison o f enrichments obtained by LC/MS and GC/MS from previous
exercise study ( Tracer tracee ratio = 205/203 x 100).

Previously analyzed
sam p les
lepolnt 203
205 205/203 LC/MS E GC/MS
-9 0
-1 5
0
5
10
20
25
30
35
40
45

191.93
305-6
2 8 4 .0 5
191.01
2 2 0 .9 7
1 9 0 .1 7
1 25.59
146.61
220.41
106.64
174.89

16.77
2 2 .4 6
2 9 .7 2
2 1 .4 5
17 .8 2
20.61
9 .7 9
11.93
19.46
1 1 .0 4
12.04

8 .7 3
7 .3 5
1 0 .4 6
11 .2 3
8 .0 6
1 0 .8 4
7 .8 0
8 .1 4
8 .8 3
1 0 .3 5
6 .8 8

-1 .3 9
1.73
2 .4 9
-0 .6 7
2 .1 0
-0 .9 4
-0 .6 0
0 .0 9
1.62
-1 .8 5

3 .1 6
3 .6
3 .2 7
3 .3 2
3 .2 3
3 .1 5
2 .9 4
3 .0 3
2 .7 8
2 .4 5

Newly acquired sam ples
epoint 203
205 205/203 LC/MS E
-6 0
-2
0
10
20
25
30
40
50

3 4 4 .8 6
157.72
175.91
122.4
161.99
2 5 2 .0 3
100.47
2 5 6 .6 9
5 7 9 .4

16.21
12 .9 3
1 8 .6 9
9 .4 0
1 5 .4 5
16.92
7 .0 5
1 5 .0 9
2 7 .8 5

4 .7 0
8 .2 0
10 .6 2
7 .6 8
9 .5 4
6.71
7 .0 2
5 .8 8
4.81

3 .5 0
5 .9 2
2 .9 8
4 .8 4
2.01
2 .3 2
1.18
0.11
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GC/MS vs. LC/MS
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Figure 3.14. GC/MS vs LC/MS enrichment data.
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Spiked standards in Water
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Experimental enrichm ent

Figure 3.15. Standard curve for glucose spiked with 1-5% [6,6^H] glucose.
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Spiked standards in plasma
6

5
R^ = 0 .1 8 7

I

4

I

3
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'C

1

oV 2
1

0
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3
4
5
Eaqaenmental enrichments

6

7

F ig u re 3.16. Standard curve for plasma samples spiked with 1-5% [6,6 H] glucose.

Sorbitol Experim ents
Sorbitol, a reduced form o f glucose, is a candidate for a tracer peak contaminant with a
m olecular weight o f approximately 182.17 amu. Sorbitol would not interfere w ith
GC/M S analysis, as it would form a hexaacetate derivative instead o f the hexaacetate
derivative that glucose forms. Figure 3.17 shows a spectrum o f sorbitol dissolved in DDI
w ater at m/z 205, the same mass as [6,6-^H] glucose. Both glucose and sorbitol peracetate
derivatives were analyzed via LC/MS (m/z 413 and 457 respectively) and are shown in
Figure 3.18 representing the large mass difference that occurs after derivatization. The
35
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glucose samples that were spiked with sorbitol are represented by a standard curve shown
in Figure 3.19 (R^ = 0.9982). As indicated by the graph, the experimental values are
approximately ten times the theoretical values. It appears that sorbitol dem onstrates a
m uch s tr o lle r (~ 10 times) interaction with sodium than glucose. For some reason the [M
+ Na]^ is m ore likely to form w ith sorbitol than w ith glucose. I f sorbitol is in the plasma,
even in small amounts, it may contaminate the isotopic glucose peak, making the peak
appear larger than predicted. Equal amounts o f glucose and sorbitol were mixed in DDI
w ater and analyzed to confirm sorbitol’s increased ability to form [M+Na]^ when
com pared to glucose. If both molecules form the ion at the same rate, then similar peak
intensities would are predicted. The results show a 205 peak that is much larger than the
glucose peak formed at 203 (Fig 3.20) practically drowning out the glucose peak at 203.
A blank plasm a sample was derivitized in an attem pt to identify sorbitol within a plasma
sample by its derivative m/z 457. The sample was prepared as described in the
m ethodology but instead o f reconstituting in DDI water, it was reconstituted in 2:1 acetic
anhydride and pyridine to form the glucose and possibly the sorbitol peracetate
derivatives. The sorbitol derivative was formed (Fig 3.21). Even small am ounts o f
sorbitol may have a large effect on tracer peak quantitation as evidenced by the standard
curve (Fig 3.19). Sorbital in trace amounts become magnified, skewing the enrichments
o f [6,6-^H] glucose. A final experiment conducted involved the addition o f equal
am ounts o f glucose pentaacetate and sorbitol hexaacetate to DDI water. A similar trend
w as observed as occurred with the native forms o f both molecules but the results were not
36

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

as drastic (Fig 3.22). The derivatization has illustrated sorbitol contained in the plasma.
Additionally, the hexaacetate derivative o f sorbitol is formed but does not interfere with
isotopic peak calculations for the determination o f enrichment. In order to identify the
contaminant molecule as sorbitol, retention tim es on a LC colum n should be analyzed. If
sorbitol elutes at the same tim e as glucose this would be convincing evidence that we
have targeted the molecule responsible for skewing enrichment data.

Sorbitol
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F ig u re 3.17. Spectrum o f Sorbitol m/z 205.
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F ig u re 3.18. Spectrum o f glucose pentaacetate (m/z 413) and sorbitol hexaacetate (m/z
457).
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G lucose spiked with Sorbitol
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F ig u re 3.19 5 mM glucose solution spiked 1-5 % with Sorbitol.
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5 mM glucose + Sorbitol
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F ig u re 3.20. Equal am ounts o f glucose and sorbitol in DDI water.
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F ig u re 3.21. Sorbitol hexaacetate detected in background plasma sample.
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F ig u re 3.22. Equal amounts o f glucose pentaacetate and sorbitol hexaacetate in DDI
water.
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m/z

C onclusion

The results suggest that o f the three ionization techniques explored, positive ion ESI
LC/MS produced the best data with respect to the signal to noise and signal intensity.
Standards prepared in water w ere accurately m easured however, standards prepared from
plasm a were not. The separation o f glucose from other molecules in plasma is not
achieved by the sample preparation and LC/MS techniques. Therefore, this LC/MS
m ethod is inadequate at determining the enrichment o f [6,6-^H] glucose in plasma.
Further research to elucidate the identity o f a contaminant molecule and the development
o f a more effective separation technique is needed. This research should investigate
using a quadrupole analyzer, w hich may increase the instruments sensitivity. Also, the
use o f carbohydrate LC columns made to separate monosaccharides will likely enhance
glucose separation. Although ESI LC/MS has revolutionized many areas o f scientific
research a definitive method for the determination o f isotopic glucose enrichment
remains elusive.

42

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Q

PAR -

& YOU

( * OuMUonnaira tar Paaata Agad t 9 ta

lanwfdtaMag*

"taUta taita.li w a y Wtaitad Imtar. aW acr«tanw i w ta W ta» «tata* ta t

ttaUttal.l|aUBBt

nn aga> « ISM ta. ta PataOaa M t«i • lau •
Ciwai TCS arMO.
m
HO
□ ' □ I.

Mtataatartatiiaatattatattanam

□

D

I.

Ca*ta#HSthH|tat itatlaatata»H

□

O

»■ t a f t a M — it a >a»a>talta l W

iiiiti'i tattastatta)

□ □ t- OttautawycwkHta
O

□

timtataittat

e t

• tataatatrtataut

S. Ottattataatana*

t ta a taatot ti law P>Vdaaatatart

O □ «. ktawtataaaitaWr
□

o r .

otyouiMaa

V E S t o o n e o r m o r e q u e s tio n s

If

■Mar«)p|MMe«rtop
L im imw itm tm tu

you
answered

NO t o all q u e s t i o n s
ea##M##»w
' »»ee<peer«^»»*

•Stt5^S$TîîS!S
I V aattai
lama aoiapHHdWa auaatoiaialia.tata ai itSoti lhadi

tSM

43

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Human Perform ance Laboratory
The University fo M ontana
P ersonal Data S h eet
N am e_______________ __________________________________________
A d d ress
__________________________________________
P h o n e N um ber(s)
__________________________________________
Age
in c a s e of
N am e
Relation
Phone
A d d ress

an em ergency, contact (closest relative)
_____________________________________
_____________________________________
_____________________________________

Menstrual History
1. Have you had a normal period for at least the last 6 m onths?

2. W hat is your history usinging oral birth control (what kind, how long)?

3. W hen w as your last period?
4. How m any d ay s is your cycle (20,30)?
Exercise History
1. D escribe th e type of exercise (duration, intensity and frequency) you participate in
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HUMAN PERFORMANCE LABORATORY
Dept of Health and Human Performance
UNIVERSITY OF MONTANA
Missoula, Montana
SUBJECT INFORMATION AND CONSENT FORM
_______
(Print Name)

ID # ________ Today’s Datej
/_____ / ______ Participant
Month Day Year

A menstrual phase comparison in eumenorrheic females:
glucose kinetics during submaximal exercise in response to an
oral glucose load - Research
STUDY DIRECTOR(S): Kristin Bourret
Brent Ruby, Ph.D.
Steven Gaskili, Ph.D.

(406)542-1296
(406)243-2117
(406) 243-4268

University of M ontana
University of M ontana
University of M ontana

This consent form may contain words that are new to you. If you read any words that are not
clear to you, please ask the person who gave you this form to explain them to you.
The purpose of this investigation is to determine if the menstrual cycle may alter which
muscle fuel (carbohydrate and fat) I use during submaximal exercise. The information
collected from this study should help determine if females have different fuel
requirements during each phase of the menstrual cycle while performing exercise.
Participation in this study will include 1) pre-screening questionnaires to determine
health and menstrual history as well as exercise training habits ("30 minutes), 2) a
measure of percent body fat obtained by measuring my body weight underwater (~ 1
hour), 3) a measure of my leg volume obtained by measuring leg circumferences, leg
length, and leg width ("20 minutes), 3) a cycling test to determine my body's maximal
ability to consume oxygen and at what intensity my anaerobic threshold occurs (~ 1
hour), 4) two 60-minute cycling trials that will involve the infusion of about 1 gram of a
glucose stable isotope ("3.5 hours each totaling 7 hours). The total time commitment is
estimated at - 9 hours and 50 minutes spread out over 4 laboratory visits.
Following the completion of the pre-screening questionnaires my leg volume and body
composition will be measured. Two different measures are necessary to calculate my
body composition (the amount of muscle and fat on your body): 1) helium breathing
technique to determine the amount of trapped air in my lungs after I exhale maximally,
and 2) underwater weighing. This procedure will require that I be seated in a large tank
of water and weighed when completely submerged with the air completely exhaled from
my lungs (I will be underwater for approximately 15 seconds per trial). For this trial, I am
to bring a bathing suit and towel. This procedure will take approximately one hour total.
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Leg volume measurements will be taken to estimate my leg muscle size. This uses a
skinfold technique, similar to what is frequently used in health clubs to estimate body
composition. The technique uses a caliper to measure specific folds of skin in different
areas of my leg. Additionally circumferences and leg diameter will be measured with a
tape measure. Leg volume measurements will take approximately 20 minutes.
The cycling maximal oxygen consumption/anaerobic threshold test will require me to
work at increasing resistance until near exhaustion. The test will require that I have a
venous catheter inserted in my arm and remain there for the duration of the test. Blood
samples will be obtained every two minutes (approximately Vz teaspoon each, total
estimate 5-6 teaspoons). I will breathe into a mouthpiece to monitor how much oxygen I
am using. This test will take approximately 1 hour.
The 60-minute cycling trial will require me to report to the Human Performance Lab early
in the morning (~5AM). indwelling venous catheters will be inserted into one vein in
each arm for blood sampling and infusion of a glucose stable isotope during rest and
cycling. I will rest on a bed for approximately 100 minutes with catheters in place before
the cycling trial. After 100 minutes I will drink a solution containing glucose in a
concentration similar to soda (22%), then I will continue to rest for 30 additional minutes
before starting exercise. The cycling trial will consist of riding an exercise bike for 60
minutes at a moderately hard intensity. This test will require that I breathe into a
mouthpiece to monitor oxygen use during exercise. This test will take approximately 3.5
hours. Blood samples will be obtained every 5 minutes during exercise and three times
before exercise totaling approximately 2.5-3.0 fluid ounces (-75 -80 mL). Transportation
will be provided for me.
I will not exercise during the 15 hours prior to any test and will not consume any food for
10 hours prior to each test (with the exception of body composition testing). I will also
provide a list of foods consumed in the previous 48 hours before the 30-minute cycling
trial. I will report to the Human Performance Laboratory in room #121 in McGill Hall for
all of my testing.
It is expected that I will have minimal discomfort as a result of my participation in this
study. Nausea and the possibility of vomiting may occur in response to the oral glucose
load. The graded cycle ergometry test has certain risks associated with it including loss
of consciousness and stroke (0.05% of the time), heart attack and death (0.005% of the
time) or musculoskeletal injury or muscle soreness. Although the risks associated with
these tests are minimal, all testing will be conducted under the guidelines for exercise
testing observed by the American College of Sports Medicine. Blood sampling (venopuncture) can sometimes be associated with risks of bruising (10%), infection (less than
1%) and clotting problems (less than 1%). All of these risks will be minimized by the use
of sterile procedures and trained technicians. There are no known risks associated with
the presence of stable isotopes in the body, as they are naturally present.
All exercise testing and blood sampling will be supervised and conducted by Brent C.
Ruby, Ph.D. an Exercise Physiologist and trained phlebotomist and his trained staff of
assistants. In the event you are injured while participating in this research study, you
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should contact Dr. Ruby in the lab (406-243-2117) or at home (406-542-2513). All
results will be kept In strict confidence among the subject Involved and the Principal
Investigators and other Co-Investigators. During the entire period of data collection,
subject records will be kept within the Human Performance Laboratory and will be locked
under the direction of the Principal Investigator.

BENEFITS OF PARTICIPATING IN THIS STUDY
1. There is no promise that you will receive any benefit from taking part in this study.
2. You will receive information concerning body composition that may be compared
with norms for your age, sex and sport. You will also receive information on your
maximal aerobic capacity and anaerobic threshold, which you may compare with
norms for your age, sex and sport. There are no other direct benefits to the
participants in the study.

CONFIDENTIALITY
1. Your records will be kept private and will not be released without your consent
except as required by law.
2. Only the researcher and his faculty supervisor will have access to the files.
3. Your identity will be kept confidential.
4. If the results of this study are written in a scientific journal or presented at a scientific
meeting, your name will not be used.
5 All data, identified only by an anonymous ID #, will be stored in our laboratory.
6. Your signed consent form and information sheet will be stored in a locked office
separate from the data.

COMPENSATION FOR INJURY
Although we believe that the risk of taking part in this study is minimal, the
following liability statement is required in all University of Montana consent forms. “In
the event that you are injured as a result of this research you should individually seek
appropriate medical treatment. If the injury is caused by negligence of the University or
any of its employees, you may be entitled to reimbursement pursuant to the
Comprehensive State Insurance Plan established by the Department of Administration
under the authority of M. C.A., Title 2, Chapter 9. In the event of a claim for such injury,
further information may be obtained from the University’s Claim representative or
University Legal Counsel, "

VOLUNTARY PARTICIPATION/WITHDRAWAL
1. You have the right to request that a test be stopped at any time.
2 Your decision to take part in this research study is entirely voluntary.
3. You may refuse to take part in or you may withdraw from the study at any time
without penalty or loss of benefits to which you are normally entitled.
4. You may leave the study for any reason.
You may be asked to leave the study for any of the following reasons:
1. Failure to follow the study investigator’s instructions.
2. A serious adverse reaction, which may require evaluation.
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3. The study director/investigator thinks it is in the best interest of your health and
welfare.
4. The study is terminated.

QUESTIONS
• You may wish to discuss this with others before you agree to take part in this study.
• If you have any questions about the research now or during the study contact: Brent
Ruby (406) 243-2117 or Steven Gaskili (406) 243-4268.
• If you have any questions regarding your rights as a research subject, you may contact
the Chairman, J.A. Rudbach, of the IRB through the Research Office at the University of
Montana at 243-6670.

SUBJECT’S STATEMENT OF CONSENT
I have read the above description of this research study. I have been informed of
the risks and benefits involved, and all my questions have been answered to my
satisfaction. Furthermore, I have been assured that a member of the research team will
also answer any future questions I may have. I voluntarily agree to take part. I
understand I will receive a copy of this consent form.
Printed (Typed) Name o f Subject

Subject’s Signature

Date

SUBJECT’S STATEMENT OF CONSENT TO BE PHOTOGRAPHED DURING DATA
COLLECTION
I provide my consent to be photographed during periods of the data collection. 1
realize that these digital images may be used during presentation of the data at regional
and national meetings.
Subject’s Signature

Date
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